Talis Biomedical Corporation (TLIS)

9.01 +0.01 (+0.11%) At close: 04:00PM EDT

Talis Biomedical Corporation

1375 West Fulton Market
Suite 700
Chicago, IL 60607
United States
650 433 3000
https://talisbio.com

Sector(s): Healthcare
Industry: Medical Devices
Full-time employees: 99

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Robert Kelley MBA	CEO & Director	852.36k	N/A	1972
Dr. Andrew A. Lukowiak Ph.D.	President & Chief Scientific Officer	904.9k	N/A	1973
Dr. Rustem F. Ismagilov Ph.D.	Co-Founder & Director	53.95k	N/A	1974
Ms. Rebecca Markovich	Interim Chief Financial Officer	379.23k	N/A	1974
Mr. Liang Li Ph.D.	Co-Founder and Director of Technology & Strategy	N/A	N/A	N/A
Ms. Emily Faucette	Senior Vice President of Corporate Communications & Investor Relations	N/A	N/A	N/A
Ms. Jill Green	Senior Vice President of Legal	N/A	N/A	N/A
Mr. Matthew Pepe	Vice President of Human Resource	N/A	N/A	N/A
Ms. Margaret Barrett M.S.	Controller	N/A	N/A	N/A
Gillian Green	Company Secretary	N/A	N/A	N/A

Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. The company was incorporated in 2013 and is headquartered in Chicago, Illinois.

Corporate governance

Talis Biomedical Corporation’s ISS governance QualityScore as of 1 April 2024 is 9. The pillar scores are Audit: 9; Board: 10; Shareholder rights: 7; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.